LYF.F EKF DIAGNOST.HLDGS.LS-01

Healthcare Medical Devices Frankfurt Exchange
0.2740 EUR
Close of Nov 12, 2026
0.2320 0.3400
Market cap
EUR 117M
P/E
27.4x
P/B
1.39x
ROE
3.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is LYF.F undervalued?

Graham number
Price0.2740
Graham value0.2103
Premium30.3%

LYF.F trades 30.3% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

EKF DIAGNOST.HLDGS.LS-01 fundamental analysis

No fundamental analysis for EKF DIAGNOST.HLDGS.LS-01 yet.

EKF DIAGNOST.HLDGS.LS-01 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About EKF DIAGNOST.HLDGS.LS-01

EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm analyzer; Hemo Control, a hemoglobin analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. It also provides glucose and lactate analyzers, such…

Full company profile